Cargando…
GSTT1, an increased risk factor for prostate cancer in patients with metabolic syndrome
BACKGROUND: Glutathione S‐transferase (GSTs) gene polymorphism and metabolic syndrome (Mets) are generally considered to be risk factors for prostate cancer (PCa). However, this conclusion is still controversial. There is a close relationship between GSTs gene polymorphism and Mets. We suspect that...
Autores principales: | Liu, Dongdong, Che, Bangwei, Chen, Pan, He, Jun, Mu, Yi, Chen, Kehang, Zhang, Wenjun, Xu, Shenghan, Tang, Kaifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993662/ https://www.ncbi.nlm.nih.gov/pubmed/35293017 http://dx.doi.org/10.1002/jcla.24352 |
Ejemplares similares
-
Primary urethral carcinoma with variant histology: A case report and literature review
por: Liu, Miao, et al.
Publicado: (2022) -
Comparison of Sutureless Versus Suture Partial Nephrectomy for Clinical T1 Renal Cell Carcinoma: A Meta-Analysis of Retrospective Studies
por: Zhang, Wenjun, et al.
Publicado: (2021) -
Prostate Microbiota and Prostate Cancer: A New Trend in Treatment
por: Che, Bangwei, et al.
Publicado: (2021) -
Molecular Mechanism of Tanshinone against Prostate Cancer
por: Li, Wei, et al.
Publicado: (2022) -
Rare primary malignant peripheral nerve sheath tumor of the left testis: A case report
por: Liu, Dongdong, et al.
Publicado: (2021)